We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current DMSBS market cap is 17.63k. The company's latest EPS is EUR -0.2805 and P/E is -3.71.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 33.54M | 33.25M | 38.51M | 35.55M | 42.37M |
| Operating Income | -2.89M | -3.57M | -1.92M | -4.4M | -1.85M |
| Net Income | -3.11M | -5.24M | -3.88M | -6.82M | -4.95M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 40.28M | 45.8M | 53.03M | 53.89M | 51.14M |
| Total Liabilities | 25.44M | 28.75M | 32.59M | 35.72M | 37.42M |
| Total Equity | 14.84M | 17.05M | 20.44M | 18.17M | 13.72M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 364k | -3.69M | -1.08M | 960k | -1.65M |
| Investing | -2.29M | 4.62M | -2.7M | -3.09M | -1.48M |
| Financing | 3.4M | 1.04M | 6.24M | 3.08M | 3.48M |
| Market Cap | 17.63k |
| Price to Earnings Ratio | -3.71 |
| Price to Sales Ratio | 0.43 |
| Price to Cash Ratio | 3.85 |
| Price to Book Ratio | 1.34 |
| Dividend Yield | - |
| Shares Outstanding | 17.63M |
| Average Volume (1 week) | 359 |
| Average Volume (1 Month) | 1.63k |
| 52 Week Change | -91.67% |
| 52 Week High | 0.03 |
| 52 Week Low | 0.0002 |
| Spread (Intraday) | 0.01 (85.71%) |
| Company Name | Diagnostic Medical Systems |
| Address |
9 avenue du canal philippe lamour la garde, var 30660 |
| Website | https://www.dms.com |
| Industry | electromedical apparatus (3845) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
